Efficacy and Safety Study With MYL-1401H and Neulasta

Mise à jour : Il y a 4 ans
Référence : NCT02467868

Femme et Homme

Extrait

This is a Multicenter, Double-Blind, Randomized, Comparative Efficacy and Safety Study of MYL-1401H and Neulasta (Pegfilgrastim) in Stage II/III Breast Cancer Patients Receiving Neoadjuvant or Adjuvant Chemotherapy.


Critère d'inclusion

  • Breast Neoplasms ,Chemotherapy-induced Febrile Neutropenia


Liens